For research use only. Not for therapeutic Use.
SWE101（Cat No.:I018086）is an experimental small-molecule compound investigated for its potential in oncology research. It functions as a selective inhibitor of metabolic and signaling pathways critical for tumor growth and survival. By disrupting cancer cell proliferation and inducing apoptosis, SWE101 provides a valuable tool for exploring novel therapeutic strategies. Preclinical studies highlight its ability to modulate cellular bioenergetics and stress responses, supporting its relevance in drug discovery. With promising activity and specificity, SWE101 serves as a research agent to advance understanding of cancer biology and targeted treatment development.
| CAS Number | 2376322-12-0 |
| Synonyms | 4-[4-(3,4-dichlorophenyl)-5-phenyl-1,3-oxazol-2-yl]butanoic acid |
| Molecular Formula | C19H15Cl2NO3 |
| Purity | ≥95% |
| IUPAC Name | 4-[4-(3,4-dichlorophenyl)-5-phenyl-1,3-oxazol-2-yl]butanoic acid |
| InChI | InChI=1S/C19H15Cl2NO3/c20-14-10-9-13(11-15(14)21)18-19(12-5-2-1-3-6-12)25-16(22-18)7-4-8-17(23)24/h1-3,5-6,9-11H,4,7-8H2,(H,23,24) |
| InChIKey | UIADWSXPNFQQCZ-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)C2=C(N=C(O2)CCCC(=O)O)C3=CC(=C(C=C3)Cl)Cl |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
